The VH repertoire and clonal diversification of B cells in inflammatory myopathies

European Journal of Immunology

Volumn 44, Issue 2, 2014, Pages 585-596

  Mcintyre, Donna ^a   Zuckerman, Neta S ^b   Field, Max ^c   Mehr, Ramit ^b   Stott, David I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BAR ILAN UNIVERSITY   (Israel)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

B cell; Clonal diversification; Myositis; Somatic hypermutation; V gene repertoire

Indexed keywords

ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SELECTION; DERMATOMYOSITIS; EXON; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL; SOMATIC HYPERMUTATION;

B CELL; CLONAL DIVERSIFICATION; MYOSITIS; SOMATIC HYPERMUTATION; V-GENE REPERTOIRE;

ANTIGENS; B-LYMPHOCYTES; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MUSCLES; MUTATION; MYOSITIS;

EID: 84893543439     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343315     Document Type: Article

References (53)

1. Dalakas, M. C. and Sivakumar, K., The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr. Opin. Neurol. 1996. 9: 235-239.
2. Dalakas, M. C. and Hohlfeld, R., Polymyositis and dermatomyositis. Lancet 2003. 362(9388): 971-982.
3. Arahata, K. and Engel, A. G., Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann. Neurol. 1984. 16: 193-208.
4. Engel, A. G. and Arahata, K., Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 1984. 16: 209-215.
5. Nagaraju, K., Raben, N., Loeffler, L., Parker, T., Rochon, P. J., Lee, E., Danning, C. et al., Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. PNAS 2000. 97: 9209-9214.
6. Larman, H. B., Salajegheh, M., Nazareno, R., Lam, T., Sauld, J., Steen, H., Kong, S. W. et al., Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann. Neurol. 2013. 73: 408-418.
7. Pluk, H., van Hoeve, B. J., van Dooren, S. H., Stammen-Vogelzangs, J., van der, H. A., Schelhaas, H. J., Verbeek, M. M. et al., Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Ann. Neurol. 2013. 73: 397-407.
8. Salajegheh, M., Lam, T. and Greenberg, S. A., Autoantibodies against a 43 KDa muscle protein in inclusion body myositis. PLoS One 2011. 6: e20266.
9. McHeyzer-Williams, L. J., Pelletier, N., Mark, L., Fazilleau, N. and McHeyzer-Williams, M. G., Follicular helper T cells as cognate regulators of B cell immunity. Curr. Opin. Immunol. 2009. 21: 266-273.
10. Schroder, A. E., Greiner, A., Seyfert, C. and Berek, C., Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. PNAS 1996. 93: 221-225.
11. Stott, D. and McIntyre, D., The Ectopic Germinal Centre Response in Autoimmune Disease and Cancer. In Huang, F.-P. (Ed.) Autoimmune Disorders - Current Concepts and Advances from Bedside to Mechanistic Insight. InTech, Rijeka, Croatia, 2011, pp. 395-432.
12. Barak, M., Zuckerman, N. S., Edelman, H., Unger, R. and Mehr, R., IgTree: creating immunoglobulin variable region gene lineage trees. J. Immunol. Methods 2008. 338: 67-74.
13. Volpe, J. M. and Kepler, T. B., Large-scale analysis of human heavy chain V(D)J recombination patterns. Immunome. Res. 2008. 4: 3.
14. Banerjee, M., Mehr, R., Belelovsky, A., Spencer, J. and Dunn-Walters, D. K., Age- and tissue-specific differences in human germinal center B cell selection revealed by analysis of IgVH gene hypermutation and lineage trees. Eur. J. Immunol. 2002. 32: 1947-1957.
15. Shahaf, G., Barak, M., Zuckerman, N. S., Swerdlin, N., Gorfine, M. and Mehr, R., Antigen-driven selection in germinal centers as reflected by the shape characteristics of immunoglobulin gene lineage trees: a large-scale simulation study. J. Theor. Biol. 2008. 255: 210-222.
16. Zuckerman, N. S., Hazanov, H., Barak, M., Edelman, H., Hess, S., Shcolnik, H., Dunn-Walters, D. et al., Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J. Autoimmun. 2010. 35: 325-335.
17. Zuckerman, N. S., Howard, W. A., Bismuth, J., Gibson, K., Edelman, H., Berrih-Aknin, S., Dunn-Walters, D. et al., Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC. Eur. J. Immunol. 2010. 40: 1150-1161.
18. Zheng, N. Y., Wilson, K., Jared, M. and Wilson, P. C., Intricate targeting of immunoglobulin somatic hypermutation maximizes the efficiency of affinity maturation. J. Exp. Med. 2005. 201: 1467-1478.
19. Greenberg, S. A., Pinkus, J. L., Pinkus, G. S., Burleson, T., Sanoudou, D., Tawil, R., Barohn, R. J. et al., Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 2005. 57: 664-678.
20. Greenberg, S. A., Bradshaw, E. M., Pinkus, J. L., Pinkus, G. S., Burleson, T., Due, B., Bregoli, L. et al., Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 2005. 65: 1782-1787.
21. Bradshaw, E. M., Orihuela, A., McArdel, S. L., Salajegheh, M., Amato, A. A., Hafler, D. A., Greenberg, S. A. et al., A local antigen-driven humoral response is present in the inflammatory myopathies. J. Immunol. 2007. 178: 547-556.
22. Salajegheh, M., Pinkus, J. L., Amato, A. A., Morehouse, C., Jallal, B., Yao, Y. and Greenberg, S. A., Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles. Muscle Nerve 2010. 42: 576-583.
23. Raju, R. and Dalakas, M. C., Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 2005. 128: 1887-1896.
24. Greenberg, S. A., Sanoudou, D., Haslett, J. N., Kohane, I. S., Kunkel, L. M., Beggs, A. H. and Amato, A. A., Molecular profiles of inflammatory myopathies. Neurology 2002. 59: 1170-1182.
25. Sims, G. P., Shiono, H., Willcox, N. and Stott, D. I., Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in Myasthenia gravis. J. Immunol. 2001. 167: 1935-1944.
26. Salomonsson, S., Jonsson, M. V., Skarstein, K., Brokstad, K. A., Hjelmstrom, P., Wahren-Herlenius, M. and Jonsson, R., Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum. 2003. 48: 3187-3201.
27. Tengner, P., Halse, A. K., Haga, H. J., Jonsson, R. and Wahren-Herlenius, M., Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren's syndrome. Arthritis Rheum. 1998. 41: 2238-2248.
28. Humby, F., Bombardieri, M., Manzo, A., Kelly, S., Blades, M. C., Kirkham, B., Spencer, J. et al., Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009. 6: 0001-0017.
29. Bhattacharya, P., Grigera, F., Rogozin, I. B., McCarty, T., Morse, H. C., III and Kenter, A. L., Identification of murine B cell lines that undergo somatic hypermutation focused to A:T and G:C residues. Eur. J. Immunol. 2008. 38: 227-239.
30. Delbos, F., Aoufouchi, S., Faili, A., Weill, J. C. and Reynaud, C. A., DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 2007. 204: 17-23.
31. Neuberger, M. S., Di Noia, J. M., Beale, R. C., Williams, G. T., Yang, Z. and Rada, C., Somatic hypermutation at A.T pairs: polymerase error versus dUTP incorporation. Nat. Rev. Immunol. 2005. 5: 171-178.
32. Neuberger, M. S. and Rada, C., Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T. J. Exp. Med. 2007. 204: 7-10.
33. Rogozin, I. B., Pavlov, Y. I., Bebenek, K., Matsuda, T. and Kunkel, T. A., Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nat. Immunol. 2001. 2: 530-536.
34. Le Panse, R., Cizeron-Clairac, G., Bismuth, J. and Berrih-Aknin, S., Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia. J. Immunol. 2006. 177: 7868-7879.
35. Meraouna, A., Cizeron-Clairac, G., Panse, R. L., Bismuth, J., Truffault, F., Tallaksen, C. and Berrih-Aknin, S., The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 2006. 108: 432-440.
36. Shlomchik, M. J., Sites and stages of autoreactive B cell activation and regulation. Immunity 2008. 28: 18-28.
37. Chung, L., Genovese, M. C. and Fiorentino, D. F., A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch. Dermatol. 2007. 143: 763-767.
38. Levine, T. D. M., Rituximab in the treatment of dermatomyositis: an Open-Label Pilot Study. Arthritis Rheum. 2005. 52: 601-607.
39. Cambridge, G., Leandro, M. J., Edwards, J. C., Ehrenstein, M. R., Salden, M., Bodman-Smith, M. and Webster, A. D., Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum. 2003. 48: 2146-2154.
40. Cambridge, G., Leandro, M. J., Teodorescu, M., Manson, J., Rahman, A., Isenberg, D. A. and Edwards, J. C., B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum. 2006. 54: 3612-3622.
41. Pers, J. O., Devauchelle, V., Daridon, C., Bendaoud, B., Le Berre, R., Bordron, A., Hutin, P. et al., BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjogren's syndrome. Arthritis Rheum. 2007. 56: 1464-1477.
42. Brochet, X., Lefranc, M. P. and Giudicelli, V., IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008. 36: W503-W508.
43. Souto-Carneiro, M. M., Longo, N. S., Russ, D. E., Sun, H. w. and Lipsky, P. E., Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J. Immunol. 2004. 172: 6790-6802.
44. Tabibian-Keissar, H., Zuckerman, N. S., Barak, M., Dunn-Walters, D. K., Steiman-Shimony, A., Chowers, Y., Ofek, E. et al., B-cell clonal diversification and gut-lymph node trafficking in ulcerative colitis revealed using lineage tree analysis. Eur. J. Immunol. 2008. 38: 2600-2609.
45. Zuckerman, N. S., McCann, K. J., Ottensmeier, C. H., Barak, M., Shahaf, G., Edelman, H., Dunn-Walters, D. et al., Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses. Int. Immunol. 2010. 22: 875-887.
46. Hershberg, U., Uduman, M., Shlomchik, M. J. and Kleinstein, S. H., Improved methods for detecting selection by mutation analysis of Ig V region sequences. Int. Immunol. 2008. 20: 683-694.
47. Abraham, R. S., Manske, M. K., Zuckerman, N. S., Sohni, A., Edelman, H., Shahaf, G., Timm, M. M. et al., Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis. J. Clin. Immunol. 2007. 27: 69-87.
48. Boursier, L., Su, W. and Spencer, J., Analysis of strand biased 'G'.C hypermutation in human immunoglobulin V(lambda) gene segments suggests that both DNA strands are targets for deamination by activation-induced cytidine deaminase. Mol. Immunol. 2004. 40: 1273-1278.
49. Dorner, T., Foster, S. J., Farner, N. L. and Lipsky, P. E., Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur. J. Immunol. 1998. 28: 3384-3396.
50. Michael, N., Martin, T. E., Nicolae, D., Kim, N., Padjen, K., Zhan, P., Nguyen, H. et al., Effects of sequence and structure on the hypermutability of immunoglobulin genes. Immunity 2002. 16: 123-134.
51. Rogozin, I. B. and Diaz, M., Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. J. Immunol. 2004. 172: 3382-3384.
52. Spencer, J. and Dunn-Walters, D. K., Hypermutation at A-T base pairs: the A nucleotide replacement spectrum is affected by adjacent nucleotides and there is no reverse complementarity of sequences flanking mutated A and T nucleotides. J. Immunol. 2005. 175: 5170-5177.
53. Weitkamp, J. H., Lafleur, B. J., Greenberg, H. B. and Crowe, J. E., Jr., Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes. Hum. Immunol. 2005. 66: 666-676.